Primary prevention of coronary heart disease with statins: it's not about the money

Circulation. 2011 Jul 12;124(2):130-2. doi: 10.1161/CIRCULATIONAHA.111.040329.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Adult
  • Aged
  • Cholesterol / blood
  • Coronary Disease / drug therapy
  • Coronary Disease / economics*
  • Costs and Cost Analysis
  • Diabetes Mellitus / chemically induced
  • Diabetes Mellitus / economics
  • Diabetes Mellitus / therapy
  • Female
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / economics*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Middle Aged
  • Models, Biological
  • Practice Guidelines as Topic
  • Risk Factors
  • Time Factors
  • United States

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol